Abstract
The 3β-hydroxysteroid dehydrogenase/isomerase (3βHSD2) enzyme plays an essential role in the synthesis of mineralocorticoids, glucocorticoids and gonadal steroids. Enzyme deficiency therefore has profound effects on adrenal and gonadal function and is a rare cause of salt-losing congenital adrenal hyperplasia and of 46XY and 46XX disorders of sex development (DSD). The disorder is characterised by excretion of excessive amounts of steroids with a double bond in the steroid B ring, the so-called Δ5 steroids, including dehydroepiandrosterone (DHEA) and its metabolites.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Further Reading
Diagnosis
Lutfallah C, Wang W, Mason I, Chang YT, et al. Newly proposed hormonal criteria via genotypic proof for type II 3β-hydroxysteroid dehydrogenase deficiency. J Clin Endocrinol Metab. 2002;87:2611–22.
Steroid Profiling
Wolthers BG, de Vries IJ, Volmer M, Nagel GT. Detection of 3β-hydroxysteroid dehydrogenase deficiency in a newborn by means of urinary steroid analysis. Clin Chim Acta. 1987;169:109–16.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Rumsby, G. (2019). 3β-Hydroxysteroid Dehydrogenase/Isomerase Deficiency. In: Rumsby, G., Woodward, G. (eds) Disorders of Steroidogenesis. Springer, Cham. https://doi.org/10.1007/978-3-319-96364-8_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-96364-8_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-96363-1
Online ISBN: 978-3-319-96364-8
eBook Packages: MedicineMedicine (R0)